Induction therapy with basiliximab allows delayed initiation of cyclosporine and preserves renal function after cardiac transplantation

Journal of Heart and Lung Transplantation

Volumn 24, Issue 9, 2005, Pages 1327-1331

  Rosenberg, Paul B ^a,b,c   Vriesendorp, Ank E ^b   Drazner, Mark H ^a,b   Dries, Daniel L ^a,b   Kaiser, Patricia A ^a   Hynan, Linda S ^a   Dimaio, J Michael ^a,b   Meyer, Daniel ^a,b   Ring, W Steves ^a,b   Yancy, Clyde W ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; BASILIXIMAB; COTRIMOXAZOLE; CYCLOSPORIN; DIPYRIDAMOLE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METHYLPREDNISOLONE SODIUM SUCCINATE; MINERAL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; VITAMIN;

ADULT; AGED; ARTICLE; CARDIAC GRAFT REJECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART TRANSPLANTATION; HIGH RISK PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERMETHOD COMPARISON; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LEUKOPENIA; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; PRIORITY JOURNAL;

ADULT; AGED; ANTIBODIES, MONOCLONAL; CREATININE; CYCLOSPORINE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; MALE; MIDDLE AGED; RECOMBINANT FUSION PROTEINS; TREATMENT OUTCOME;

EID: 24344487987     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2004.08.003     Document Type: Article

References (17)

1. C. Magee, M. Pascual The growing problem of chronic renal failure after transplantation of a nonrenal organ N Engl J Med 349 2003 994 996
2. B.D. Myers, J. Ross, L. Newton, J. Luetscher, M. Perlroth Cyclosporine-associated chronic nephropathy N Engl J Med 311 1984 699 705
3. M.R. Vossler, H. Ni, W. Toy, R.E. Hershberger Pre-operative renal function predicts development of chronic renal insufficiency after orthotopic heart transplantation J Heart Lung Transplant 21 2002 874 881
4. D.N. Cruz, M.A. Perazella Acute renal failure after cardiac transplantation a case report and review of the literature Yale J Biol Med 69 1996 461 468
5. C.J. Dunn, A.J. Wagstaff, C.M. Perry, G.L. Plosker, K.L. Goa Cyclosporin an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation Drugs 61 2001 1957 2016
6. B. Nashan, R. Moore, P. Amlot, A.G. Schmidt, K. Abeywickrama, J.P. Soulillou CHIB 201 International Study Group Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients Lancet 350 1997 1193 1198
7. A. Beniaminovitz, S. Itescu, K. Lietz Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody N Engl J Med 342 2000 613 619
8. R. Gordon 2003 Safety Alert Zenapax (daclizumab) Dear Health Care Professional Letter 2003
9. R. Kode, K. Fa, S. Chowdhury Basiliximab plus low-dose cyclosporin vs. OKT3 for induction immunosuppression following renal transplantation Clin Transplant 17 2003 369 376
10. M.T. Olivari, S.H. Kubo, E.A. Braunlin, R.M. Bolman, W.S. Ring Five-year experience with triple-drug immunosuppressive therapy in cardiac transplantation Circulation 82 5 Suppl 1990 IV276 IV280
11. A.O. Ojo, P.J. Held, F.K. Port Chronic renal failure after transplantation of a nonrenal organ N Engl J Med 349 2003 931 940
12. T. van Gelder, A.H. Balk, R. Zietse, C. Hesse, B. Mochtar, W. Weimar Renal insufficiency after heart transplantation a case-control study Nephrol Dial Transplant 13 1998 2322 2326
13. R.G. Woolfson, G.H. Neild Cyclosporin nephrotoxicity following cardiac transplantation Nephrol Dial Transplant 12 1997 2054 2056
14. B. Geny, G. Brandenberger, J. Lonsdorfer, N. Chakfe, P. Haberey, F. Piquard Circulating adrenomedullin is increased after heart transplantation Cardiovasc Res 41 1999 731 736
15. M. Bunke, B. Ganzel Effect of calcium channel antagonists on renal function in hypertensive heart transplant recipients J Heart Lung Transplant 11 1992 1194 1199
16. R.J. Tesi, J. Hong, K.M. Butt, B.M. Jaffe, M.A. McMillen In vivo potentiation of cyclosporine immunosuppression by calcium antagonists Transplant Proc 19 1987 1382 1384
17. H. Sacks, T.C. Chalmers, H. Smith Jr. Randomized versus historical controls for clinical trials Am J Med 72 1982 233 240